(Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | (Q3)Oct 31, 2023 | (Q2)Jul 31, 2023 | (Q1)Apr 30, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 109.54%113.84K | -2,042.57%-717.89K | 52.81%-5.68M | 94.50%-3.71M | -96.75%-744.11K | -102.08%-1.19M | 98.08%-33.51K | -12.03M | -67.38M | -22.71%-378.2K |
Net income from continuing operations | 40.35%-744.17K | -11.09%-490.62K | -132.30%-16.83M | -13,531.25%-14.45M | -142.68%-696.84K | -102.27%-1.25M | 81.40%-441.65K | --52.1M | ---105.97K | 75.19%-287.14K |
Operating gains losses | --284 | --16.87K | 99.57%-289.57K | ---461.53K | --0 | ---- | ---- | ---67.82M | ---- | ---- |
Depreciation and amortization | 2,753.84%214.04K | 2,753.84%214.04K | --440.98K | --418.48K | --7.5K | --7.5K | --7.5K | ---- | ---- | ---- |
Asset impairment expenditure | ---- | ---- | --247.22K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | ---- | ---- | --10.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Remuneration paid in stock | -92.35%16.68K | -95.70%16.68K | 16.92%615.11K | -97.83%9.12K | --0 | 585.21%217.99K | 769.33%388K | --526.11K | --421.2K | -88.12%28.46K |
Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Other non cashItems | --12.95K | 158.99%43.62K | --3.51M | --3.51M | --75.03K | --0 | ---73.95K | ---- | ---- | ---- |
Change In working capital | 279.06%614.05K | -698.78%-518.49K | -221.36%-3.84M | -200.99%-3.45M | -8.60%-129.81K | 52.25%-342.93K | -85.13%86.59K | --3.16M | --3.42M | -119.95%-119.53K |
-Change in receivables | 278.66%349.75K | 121.85%5.5K | -162.10%-363.75K | -842.58%-137.41K | -100.78%-5.4K | 59.63%-195.76K | -106.34%-25.19K | --585.71K | ---14.58K | 935.56%687.64K |
-Change in prepaid assets | 103.55%18.18K | -742.28%-516.36K | -888.51%-315.72K | -11,529.43%-112.22K | 2,198.76%227.78K | -7,115.91%-511.67K | 80.40%80.4K | --40.04K | ---965 | -101.64%-10.85K |
-Change in payables and accrued expense | -26.33%268.53K | -55.47%13.97K | -227.21%-3.22M | -204.03%-3.27M | 55.77%-352.19K | 641.84%364.5K | -77.65%31.38K | --2.53M | --3.14M | -4,426.60%-796.31K |
-Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --289.8K | --0 |
-Change in other working capital | ---22.4K | ---21.6K | --68.23K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 109.54%113.84K | -2,042.56%-717.89K | 52.81%-5.68M | 94.50%-3.71M | -96.75%-744.11K | -102.08%-1.19M | 98.08%-33.51K | ---12.03M | ---67.38M | 63.22%-378.2K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 0 | -98.08%1.3M | 3.37M | -245.79K | -2.39M | 116.36%566.97K | 67.82M | ||
Net PPE purchase and sale | ---- | ---- | 30.01%-2.57M | --0 | ---177.74K | ---- | ---- | ---3.67M | ---- | ---- |
Net business purchase and sale | ---- | ---- | --3.87M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | --0 | --0 | --566.97K | --71.49M | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | --0 | -98.08%1.3M | -95.03%3.37M | ---245.79K | -168.97%-2.39M | 116.36%566.97K | --67.82M | --67.82M | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | 108.59%5.59M | 25.12%-170.57K | 500K | 106.02%4.04M | -49.86%1.22M | -65.01M | -227.8K | 0 |
Net issuance payments of debt | ---- | ---- | ---1M | ---170.57K | --0 | ---- | ---- | --0 | ---- | ---- |
Net common stock issuance | --0 | --0 | --6.59M | --0 | --500K | 1,581.47%4.87M | --1.22M | --0 | ---289.8K | --0 |
Cash dividends paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---68.26M | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --3.25M | --62K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | --0 | 108.59%5.59M | 25.12%-170.57K | --500K | 106.02%4.04M | -49.86%1.22M | ---65.01M | ---227.8K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -57.19%939.09K | 272.45%1.66M | -96.64%444.89K | -43.26%2.16M | -36.68%2.65M | -79.00%2.19M | -96.64%444.89K | --13.24M | --3.81M | -72.85%4.19M |
Current changes in cash | -75.19%113.84K | -141.05%-717.89K | 113.15%1.21M | -345.70%-505.5K | -29.54%-489.9K | 107.33%458.76K | 162.69%1.75M | ---9.22M | --205.74K | 63.22%-378.2K |
End cash Position | -60.30%1.05M | -57.19%939.09K | -58.75%1.66M | -58.75%1.66M | -43.26%2.16M | -36.68%2.65M | -79.00%2.19M | --4.02M | --4.02M | -73.54%3.81M |
Free cash from | 103.18%113.84K | -2,042.56%-717.89K | 47.48%-8.24M | 94.88%-3.64M | -161.74%-989.9K | -105.88%-3.58M | 99.36%-33.51K | ---15.7M | ---71.05M | 63.22%-378.2K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data